Effectiveness of COVID-19 Vaccination on Transmission: A Systematic Review

被引：18

作者：

Oordt-Speets, Anouk ^{[1
]}

Spinardi, Julia ^{[2
]}

Mendoza, Carlos ^{[3
]}

Yang, Jingyan ^{[4
]}

Morales, Graciela ^{[5
]}

Mclaughlin, John M. ^{[6
]}

Kyaw, Moe H. ^{[6
]}

机构：

[1] Epi C Epidemiol Consultancy, NL-3846 AG Harderwijk, Netherlands

[2] Pfizer Inc, Vaccine Med Affairs, Emerging Mkts, BR-06696270 Itapevi, Brazil

[3] Pfizer Inc, Patient Hlth & Impact, Mexico City 05120, Mexico

[4] Pfizer Inc, Global Value & Access, New York, NY 10017 USA

[5] Pfizer Inc, Vaccine Med Affairs, Emerging Markets, New York, NY 10017 USA

[6] Pfizer Inc, Vaccine Sci Affairs, New York, NY 10017 USA

来源：

COVID | 2023年 / 3卷 / 10期

关键词：

SARS-CoV-2; COVID-19; vaccination; transmission; viral load; INFECTION;

D O I：

10.3390/covid3100103

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Vaccination against infectious disease affords direct protection from vaccine-induced immunity and additional indirect protection for unvaccinated persons. A systematic review was conducted to estimate the indirect effect of COVID-19 vaccination. From PubMed and Embase, 31 studies were included describing the impact of original wild-type COVID-19 vaccines on disease transmission or viral load. Overall, study results showed the effectiveness of COVID-19 vaccination against SARS-CoV-2 transmission (range 16-95%), regardless of vaccine type or number of doses. The effect was apparent, but less pronounced against omicron (range 24-95% for pre-omicron variants versus 16-31% for omicron). Results from viral load studies were supportive, showing SARS-CoV-2 infections in vaccinated individuals had higher Ct values, suggesting lower viral load, compared to infections among the unvaccinated. Based on these findings, well-timed vaccination programs may help reduce SARS-CoV-2 transmission-even in the omicron era. Whether better-matched vaccines can improve effectiveness against transmission in the omicron era needs further study.

引用

页码：1516 / 1527

页数：12

共 57 条

[1] Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections [J].

Abu-Raddad, Laith J. ;

Chemaitelly, Hiam ;

Ayoub, Houssein H. ;

Tang, Patrick ;

Coyle, Peter ;

Hasan, Mohammad R. ;

Yassine, Hadi M. ;

Benslimane, Fatiha M. ;

Al-Khatib, Hebah A. ;

Al-Kanaani, Zaina ;

Al-Kuwari, Einas ;

Jeremijenko, Andrew ;

Kaleeckal, Anvar Hassan ;

Latif, Ali Nizar ;

Shaik, Riyazuddin Mohammad ;

Abdul-Rahim, Hanan F. ;

Nasrallah, Gheyath K. ;

Al-Kuwari, Mohamed Ghaith ;

Butt, Adeel A. ;

Al-Romaihi, Hamad Eid ;

Al-Khal, Abdullatif ;

Al-Thani, Mohametabd H. ;

Bertollini, Roberto .

NATURE COMMUNICATIONS, 2022, 13 (01)

[2] Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study [J].

Allen, Hester ;

Vusirikala, Amoolya ;

Flannagan, Joe ;

Twohig, Katherine A. ;

Zaidi, Asad ;

Chudasama, Dimple ;

Lamagni, Theresa ;

Groves, Natalie ;

Turner, Charlie ;

Rawlinson, Christopher ;

Lopez-Bernal, Jamie ;

Harris, Ross ;

Charlett, Andre ;

Dabrera, Gavin ;

Kall, Meaghan .

LANCET REGIONAL HEALTH-EUROPE, 2022, 12

[3] Can Testing Predict SARS-CoV-2 Infectivity? The Potential for Certain Methods To Be Surrogates for Replication-Competent Virus [J].

Binnicker, Matthew J. .

JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (11)

[4] Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021 [J].

Braeye, Toon ;

Cornelissen, Laura ;

Catteau, Lucy ;

Haarhuis, Freek ;

Proesmans, Kristiaan ;

De Ridder, Karin ;

Djiena, Achille ;

Mahieu, Romain ;

De Leeuw, Frances ;

Dreuw, Alex ;

Hammami, Naima ;

Quoilin, Sophie ;

Van Oyen, Herman ;

Wyndham-Thomas, Chloe ;

Van Cauteren, Dieter .

VACCINE, 2021, 39 (39) :5456-5460

[5] Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms [J].

Bramante, Carolyn T. ;

Proper, Jennifer L. ;

Boulware, David R. ;

Karger, Amy B. ;

Murray, Thomas ;

Rao, Via ;

Hagen, Aubrey ;

Tignanelli, Christopher J. ;

Puskarich, Michael ;

Cohen, Ken ;

Liebovitz, David M. ;

Klatt, Nichole R. ;

Broedlow, Courtney ;

Hartman, Katrina M. ;

Nicklas, Jacinda ;

Ibrahim, Sherehan ;

Zaman, Adnin ;

Saveraid, Hanna ;

Belani, Hrishikesh ;

Ingraham, Nicholas ;

Christensen, Grace ;

Siegel, Lianne ;

Sherwood, Nancy E. ;

Fricton, Regina ;

Lee, Sam ;

Odde, David J. ;

Buse, John B. ;

Huling, Jared D. .

OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (05)

[6]

Cochrane Emergency Critical Care Group, 2023, Cochrane Database Syst. Rev, V12, pCD015477

[7] Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021 [J].

de Gier, Brechje ;

Andeweg, Stijn ;

Backer, Jantien A. ;

Hahne, Susan J. M. ;

van den Hof, Susan ;

de Melker, Hester E. ;

Knol, Mirjam J. .

EUROSURVEILLANCE, 2021, 26 (44)

[8] Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants [J].

Eyre, David W. ;

Taylor, Donald ;

Purver, Mark ;

Chapman, David ;

Fowler, Tom ;

Pouwels, Koen B. ;

Walker, A. Sarah ;

Peto, Tim E. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (08) :744-756

[9] Indirect protection of children from SARS-CoV-2 infection through parental vaccination [J].

Hayek, Samah ;

Shaham, Galit ;

Ben-Shlomo, Yatir ;

Kepten, Eldad ;

Dagan, Noa ;

Nevo, Daniel ;

Lipsitch, Marc ;

Reis, Ben Y. ;

Balicer, Ran D. ;

Barda, Noam .

SCIENCE, 2022, 375 (6585) :1155-+

[10] What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 [J].

Hodgson, Susanne H. ;

Mansatta, Kushal ;

Mallett, Garry ;

Harris, Victoria ;

Emary, Katherine R. W. ;

Pollard, Andrew J. .

LANCET INFECTIOUS DISEASES, 2021, 21 (02) :E26-E35

← 1 2 3 4 5 6 →